ISLAMABAD – Pakistan and China signed nine business-to-business (B2B) agreements worth more than $440 million in the pharmaceutical sector on Friday, covering local vaccine production, biotechnology, pharmaceutical manufacturing, technology transfer and hepatitis prevention. The agreements were signed during the Pakistan-China Pharmaceutical Companies Business Conference in Islamabad, attended by Prime Minister Shehbaz Sharif, senior government officials, The post Pakistan, China sign $440 million pharmaceutical deals to boost local vaccine production appeared first on Daily Pakistan English News.



